Search - tctmd.com

Displaying 281 - 300 of 1134

Sort: Relevancy | Date

Presentation NY Valves 2024

CT Observations On Achieving the "Optimal" TAVR Implantation: Can We Avoid TAVR Failures?

Presenter: Joao L. Cavalcante

June 07, 2024

Presentation NY Valves 2024

Pathobiologic Insights From TAVR Explants

Presenter: Stephanie Sellers

June 07, 2024

Presentation NY Valves 2024

Surgical Explants for Failed TAVR: Frequency, Outcomes, and Clinical Implications

Presenter: Vinayak N. Bapat

June 07, 2024

Presentation NY Valves 2024

TAVR Durability: What Do We Know So Far?

Presenter: Helene Eltchaninoff

June 07, 2024

Presentation NY Valves 2024

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

Presenter: Philippe Pibarot

June 07, 2024

Presentation NY Valves 2024

There Is Growing Evidence to Support Earlier AS Treatment: Guidelines and Clinical Practice Are Lagging Behind!

Presenter: Philippe Genereux

June 07, 2024

Presentation NY Valves 2024

Access Disparities Affecting Appropriate AS Therapy

Presenter: David A. Wood

June 07, 2024

Presentation NY Valves 2024

Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program

Presenter: Brian R. Lindman

June 07, 2024

Presentation NY Valves 2024

Thoughts on Therapy Sequencing in Younger Patients With AS and Long Life Expectancy

Presenter: Michael J. Reardon

June 07, 2024

Presentation NY Valves 2024

Patient Interview: Understanding the Impact of Patient Preferences and Other Determinants of VHD Therapy Choices

Presenter: Robert L. Smith, Megan Coylewright

June 07, 2024

Presentation NY Valves 2024

CON: TMVR Has too Many Problems – Just Do M-TEER

Presenter: Saibal Kar

June 06, 2024

Presentation NY Valves 2024

PRO: TMVR Is a Good Option for Functional MR

Presenter: Chet Rihal

June 06, 2024

Presentation NY Valves 2024

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

Presenter: Javed Butler

June 06, 2024

Presentation NY Valves 2024

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

Presenter: Michael Joseph Rinaldi

June 06, 2024

Presentation NY Valves 2024

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Presenter: JoAnn Lindenfeld

June 06, 2024

Presentation NY Valves 2024

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Presenter: Anna Sannino

June 06, 2024

Presentation NY Valves 2024

Case 2: TAVR in MAC With Lampoon and Sapien – Step-by-step Approach and Clinical Outcomes

Presenter: Adam B. Greenbaum

June 06, 2024

Presentation NY Valves 2024

Case 1: MAC Treated With Commercial TMVR (Tendyne) – Technical Considerations

Presenter: Jason H. Rogers

June 06, 2024

Presentation NY Valves 2024

Pro-Surgery

Presenter: James M. McCabe

June 06, 2024

Presentation NY Valves 2024

Pro-TMVR

Presenter: Tsuyoshi Kaneko

June 06, 2024

Advertisement

CT Observations On Achieving the "Optimal" TAVR Implantation: Can We Avoid TAVR Failures?

Pathobiologic Insights From TAVR Explants

Surgical Explants for Failed TAVR: Frequency, Outcomes, and Clinical Implications

TAVR Durability: What Do We Know So Far?

UPDATES: Pre-emptive AVR Clinical Trials for Moderate and Severe AS

There Is Growing Evidence to Support Earlier AS Treatment: Guidelines and Clinical Practice Are Lagging Behind!

Access Disparities Affecting Appropriate AS Therapy

Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program

Thoughts on Therapy Sequencing in Younger Patients With AS and Long Life Expectancy

Patient Interview: Understanding the Impact of Patient Preferences and Other Determinants of VHD Therapy Choices

CON: TMVR Has too Many Problems – Just Do M-TEER

PRO: TMVR Is a Good Option for Functional MR

Treatment Options for Functional MR: ADVANCED GDMT, M-TEER, TMVR, and Surgery – What Does the Evidence Show?

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Case 2: TAVR in MAC With Lampoon and Sapien – Step-by-step Approach and Clinical Outcomes

Case 1: MAC Treated With Commercial TMVR (Tendyne) – Technical Considerations

Pro-Surgery

Pro-TMVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content